close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar21Point90
Implied share price

Sell Overvalued by 71.3%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
AMGN
Amgen, Inc.
Change
NVO
Novo Nordisk A/S (ADR)
Change
SNY
Sanofi SA (ADR)
Change
GILD
Gilead Sciences, Inc.
Change
6.47 23.69 12.04 2.44 5.61 4.96
All amounts in millions
from last financial year
         
Implied Share Price $21.90 $91.78 $137.42 $49.78 $107.67
Market Cap 18,291 128,217 113,067 108,606 108,197
Net Debt -371 47 -19,392 7,295 7,450
Enterprise Value (EV) 18,961 128,264 121,835 62,527 115,580
Revenue 4,048 21,662 107,927 34,861 32,639
EBITDA 800 10,657 50,027 11,136 23,287
Percent 19.8 % 49.2 % 46.4 % 31.9 % 71.3 %
EBIT 332 8,530 47,068 7,186 22,189
Percent 8.2 % 39.4 % 43.6 % 20.6 % 68.0 %
Balance Sheet          
Total Assets 10,913 71,449 91,799 102,321 51,716
Total Liabilities 3,326 43,366 44,830 44,272 33,182
Shareholders Equity 7,586 28,083 46,969 58,049 18,534.0

Comments

No comments yet. Login to comment.